Preview Mode Links will not work in preview mode

Oncology Overdrive

Feb 2, 2023

In this episode, host Shikha Jain, MD, speaks with Christopher Heery, MD, of Arcellx, Inc. about making the transition from physician to chief medical officer, providing more access and education for clinical trials and more.

  • Welcome to another exciting episode of Oncology Overdrive :14
  • About Heery :25
  • The interview 3:06
  • Tell us a little bit about your journey. How did you get to where you are today? 3:21
  • Do you have any advice for those who are interested in making the transition into roles like CMO? How would you guide somebody who is interested in doing that? 7:29
  • Jain and Heery on the transition in many physicians from patient care to health care leaders and retaining people in clinical medicine 10:41
  • Jain and Heery on the disconnect in understanding health care costs 13:42
  • About Arcellx, Inc. and what is coming down the pipeline 15:34
  • Jain and Heery on how far cancer care has evolved, and the challenge of making this care more accessible to underserved communities 21:30
  • Jain and Heery on the challenge misinformation creating fear and educating about treatment, clinical trials and immunotherapy 27:23
  • Jain and Heery on the growing mistrust in the health care system and its effects on the doctor-patient relationship 34:52
  • If someone could only listen to the last minute or two of this episode, what would you want them to take away? 42:11
  • How to contact Heery 43:18
  • Thanks for listening 43:56

Christopher Heery, MD, has been the chief medical officer of Arcellx, Inc. since April 2021. Prior to that, he served as chief medical officer at Precision BioSciences and Bavarian Nordic. Heery is board-certified in medical oncology and internal medicine.  

We’d love to hear from you! Send your comments/questions to Dr. Jain at Follow us on Twitter @HemOncToday and @ShikhaJainMD. Heery can be reached on Twitter @ChrisHeery.